|
|
Volumn 35, Issue 4, 2001, Pages 179-182
|
|
Drugs for the treatment of Alzheimer's disease
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACECLIDINE;
AMIRIDINE;
AMYLOID BETA PROTEIN;
ANTIOXIDANT;
AXELON;
BETHANECHOL;
CHOLINE;
CHOLINERGIC RECEPTOR STIMULATING AGENT;
CHOLINESTERASE INHIBITOR;
DONEPEZIL;
EPTASTIGMINE;
GALANTAMINE;
MEMANTINE;
METRIFONATE;
MUSCARINIC M1 RECEPTOR;
NEBRACETAM;
NEFIRACETAM;
NEOSTIGMINE;
PHOSPHATIDYLCHOLINE;
PHYSOSTIGMINE;
PIRACETAM;
PYRIDOXINE;
RIVASTIGMINE;
SABELUZOLE;
TACRINE;
TALSACLIDINE;
TAZOMELIN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VELNACRINE;
VELNACRINE MALEATE;
XANOMELINE;
ALZHEIMER DISEASE;
BLOOD BRAIN BARRIER;
DRUG CLASSIFICATION;
DRUG EFFICACY;
DRUG ISOLATION;
DRUG MECHANISM;
DRUG PENETRATION;
DRUG PROTEIN BINDING;
DRUG RESEARCH;
DRUG STRUCTURE;
DRUG SYNTHESIS;
DRUG TOLERABILITY;
HUMAN;
NONHUMAN;
PATHOGENESIS;
REVIEW;
STRUCTURE ACTIVITY RELATION;
|
|
EID: 0035174248
PISSN: 0091150X
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1010474325601 Document Type: Review |
|
Times cited : (16)
|
|
References (10)
|
